Closing Soon
Observation study of Opioid Dependency patients, sponsored by DemeRx Inc
Get in touch This trial recruits from May 2013 for 2 weeks
Ms Linda Folland
Phone: +64 3 477 9669
Email: Linda.Folland@zenithtechnology.co.nz
Address:
Zenith Technology Ltd
156 Frederick Street
(P O Box 1777)
Dunedin 9016
Inclusion Criteria
Age: From 18 years To 55 years
Gender: Both males and females
The main inclusion criteria are opioid dependent male and female adults (18-55 years) who provide written consent and are on stable doses of methadone through the OST programme. Participants cannot have any other major illnesses or disorders and must be willing to comply with the restrictions of the study.
Exclusion Criteria
Exclusion criteria include current treatment for hepatitis C; HIV positive; DSM IV Axis I diagnosis of psychotic disorders; specified excluded concomitant medications; DSM IV criteria for dependence on substances other than opioids, caffeine, and/or nicotine.
ACTRN12613000539730
Evaluation of Instruments and Procedures Used to Measure Opioid Withdrawal in Opioid Dependent Participants Who are Seeking to Discontinue Methadone Opioid Substitution Treatment (OST)
Evaluation of Instruments and Procedures Used to Measure Opioid Withdrawal in Opioid Dependent Participants Who are Seeking to Discontinue Methadone Opioid Substitution Treatment (OST)